Business · 27/04/2022Updated: 10/17/2026 · 1 min read
FDA Clears FOLVITE Tablets for Sale, Citing Lack of Safety or Effectiveness Concerns
Summary
The US Food and Drug Administration (FDA) has announced that it will not withdraw approval of FOLVITE oral tablets, which contain 1 milligram of folic acid, due to concerns over safety or effectiveness, allowing the products to remain on the market.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →